Discontinuation report FUZEON
| Report ID | 239548 |
| Drug Identification Number | 02247725 |
| Brand name | FUZEON |
| Common or Proper name | ENFUVIRTIDE |
| Company Name | HOFFMANN-LA ROCHE LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ENFUVIRTIDE |
| Strength(s) | 108MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 60 X 3ML VIAL |
| ATC code | J05AX |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for discontinuation | Manufacturing issues |
| Anticipated discontinuation date | 2025-03-31 |
| Actual discontinuation date | |
| Remaining supply date | 2025-03-31 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7070 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 5M8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-10-07 | French | Compare |
| v1 | 2024-10-07 | English | Compare |
Showing 1 to 2 of 2